Delivery Order SPE2DR25D1205-SPE2DR26F1AJ2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,034.01 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on December 19, 2025, with an ultimate completion date of December 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction supporting federal medical supply needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $1,729.69 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of January 15, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as the corporate headquarters for the awardee. This delivery order represents a task order issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,581.65 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of January 12, 2026. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military...
- The Defense Logistics Agency awarded a $9,963.87 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on January 8, 2026, with completion scheduled for January 9, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,139.62 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials. This contract employs firm fixed price terms with an ultimate completion date of November 25, 2025, and was awarded competitively without a set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $5,126.06 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with a completion deadline of January 15, 2026. The contract was competitively awarded without set-aside designation using firm fixed-price terms. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,564.63 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of November 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies medications, vaccines, medical devices, and...
- The Defense Logistics Agency awarded a delivery order valued at $1,763.46 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract utilizing the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $47,038.50 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. The award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters and primary distribution hub for...
- The Defense Logistics Agency awarded a $18,242.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with a completion date of November 13, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F1AJ2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,259.06 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of January 22, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp serves as a critical vendor in the federal pharmaceutical supply chain, providing vaccines, medications, medical devices, and specialized healthcare commodities to military treatment facilities and other government healthcare systems. The company's extensive contract portfolio with DLA demonstrates its capability to efficiently fulfill federal medical procurement requirements across multiple therapeutic domains through open competition. This vaccine delivery supports the Department of Defense's healthcare supply chain needs and aligns with the broader pharmaceutical prime vendor strategy established by DLA Troop Support Medical.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/20/26 |